Stile Pharmaceuticals Private Limited

Stile Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN U24297MH2014PTC257973 Incorporated 10 September 2014 ROC Mumbai HQ Thane, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹12.88 Lakh
▼ 9% YoY
Net profit · FY 2024
₹5,186
Net margin 0.4%
EBITDA · FY 2024
₹35,308
EBITDA margin 2.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Stile Pharmaceuticals Private Limited

Data last updated:

Stile Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 September 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24297MH2014PTC257973. Its GSTIN is 27AAUCS9575R1ZR (Maharashtra).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Harish Shivcharan Kandpal and Padhma Ballapa Philcheli.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at R N P Park, Thane, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹12.88 Lakh, a decline of 9% compared to the previous year. For the same year it recorded a net profit of ₹5,186 (net margin 0.4%) and EBITDA of ₹35,308 (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 2% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Stile Pharmaceuticals Private Limited
CIN U24297MH2014PTC257973
Registration Number 257973
Incorporation Date 10 September 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Flat No B – 207 Pawan Palace Chs Ltd Kashi Vishwanath Nagar, R N P Park Nr Ostwal Bagechi, Thane, Maharashtra, India – 401105
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Stile Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Stile Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Stile Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Stile Pharmaceuticals Private Limited

The main business activity of Stile Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
GTradeG1Wholesale TradingLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Stile Pharmaceuticals Private Limited FY 2025 filings available

Stile Pharmaceuticals Private Limited reported revenue of ₹12.88 Lakh (down 9% YoY) for FY 2024.

Revenue · FY 2024
₹12.88 Lakh ▼ 9%
Net profit · FY 2024
₹5,186 margin 0.4%
EBITDA · FY 2024
₹35,308 margin 2.7%

Compounded Annual Growth Rate (CAGR) of Stile Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▼ 9%
3 years · compounded
▲ 9%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 14%
5 years · compounded
▲ 32%

Revenue has declined at a compounded annual rate (CAGR) of 2% over five years, including a 9% fall in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Stile Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹35,308••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹5,186••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Stile Pharmaceuticals Private Limited

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin2.7%••••••••••••••••
Net Profit Margin0.4%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stile Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Stile Pharmaceuticals Private Limited

Stile Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Harish Shivcharan KandpalDirector10 Sep 201412 Years 1 MonthsCurrent
Padhma Ballapa PhilcheliDirector10 Sep 201412 Years 1 MonthsCurrent

Peer Comparison of Stile Pharmaceuticals Private Limited

Stile Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mac Remedies Private Limited₹12.9 Lakh (FY 2025)••••••••••••Mumbai, Maharashtra, India
Sukem Pharmaceuticals Private Limited₹12.9 Lakh (FY 2025)••••••••7.0%••••New Delhi, Delhi, India
Dwaraka Ayurvedic Pharmaceuticals (P) Ltd₹12.89 Lakh (FY 2025)••••••••-17.0%••••Palghat, Kerala, India
Shreeshiddivinayak Pharmaceuticals Private Limited₹12.89 Lakh (FY 2022)••••••••615.0%••••Gwalior, Madhya Pradesh, India
Kensho Healthcare Private Limited₹12.88 Lakh (FY 2025)••••••••••••Bangalore, Karnataka, India
Stile Pharmaceuticals Private Limited this company₹12.88 Lakh (FY 2024)••••••••-9.0%••••Thane, Maharashtra, India
D Cross Pharmaceuticals Private Limited₹12.86 Lakh (FY 2025)••••••••34.0%••••Delhi, India
Bionek Pharmaceuticals Private Limited₹12.85 Lakh (FY 2025)••••••••5.0%••••Varanasi, Uttar Pradesh, India
Aysha Davakhana Ayurveda Pharmaceuticals Private Limited₹12.82 Lakh (FY 2025)••••••••176.0%••••Vatakara, Kerala, India
Soukq Pharma Private Limited₹12.82 Lakh (FY 2025)••••••••-86.0%••••New Delhi, Delhi, India
Jodeera Pharmaceuticals Private Limited₹12.81 Lakh (FY 2022)••••••••216.0%••••Jalgaon, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Stile Pharmaceuticals by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Stile Pharmaceuticals Private Limited

Stile Pharmaceuticals Private Limited is audited by SURENDRA AGARWAL & ASSOCIATES for the financial year 2020.

NameStatusAppointment DateCessation Date
SURENDRA AGARWAL & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Stile Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Stile Pharmaceuticals Private Limited

Stile Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Stile Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Stile Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Stile Pharmaceuticals Private Limited

Stile Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Harish Shivcharan Kandpal was appointed as Director on 10 Sep 2014.

AGM
Stile Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Stile Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Harish Shivcharan Kandpal was appointed as Director.
Appointed
Padhma Ballapa Philcheli was appointed as Director.
Incorporation
10 Sep 2014
Stile Pharmaceuticals Private Limited was registered on 10 Sep 2014 with Roc Mumbai Ii & aged 12 years 1 month as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Stile Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Stile Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Stile Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Stile Pharmaceuticals Private Limited

Stile Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAUCS9575R1ZRMaharashtraActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Stile Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Stile Pharmaceuticals Private Limited

Stile Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 September 2014 (12+ years old) and is registered under CIN U24297MH2014PTC257973.

Stile Pharmaceuticals reported revenue of ₹12.88 Lakh for FY 2024 (down 9% YoY).

Stile Pharmaceuticals has 2 current directors:

Stile Pharmaceuticals reported a net profit of ₹5,186 (net margin 0.4%) and EBITDA of ₹35,308 (EBITDA margin 2.7%) for FY 2024, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Stile Pharmaceuticals is 9% over three years and -2% over five years. In the latest year (FY 2024) revenue fell 9%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Stile Pharmaceuticals is 27AAUCS9575R1ZR, registered in Maharashtra.

The CIN (Corporate Identification Number) of Stile Pharmaceuticals is U24297MH2014PTC257973. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Stile Pharmaceuticals was incorporated on 10 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Stile Pharmaceuticals by revenue are Mac Remedies Private Limited, Sukem Pharmaceuticals Private Limited, Dwaraka Ayurvedic Pharmaceuticals (P) Ltd, Shreeshiddivinayak Pharmaceuticals Private Limited, Kensho Healthcare Private Limited and 5 more, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals).

Harish Shivcharan Kandpal was appointed as Director on 10 Sep 2014. Padhma Ballapa Philcheli was appointed as Director on 10 Sep 2014.

The registered office of Stile Pharmaceuticals is at Flat No B – 207 Pawan Palace Chs Ltd Kashi Vishwanath Nagar, R N P Park Nr Ostwal Bagechi, Thane, Maharashtra, India – 401105.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available